Skye Bioscience, Inc is a San Diego-based pharmaceutical company focused on developing proprietary molecules to treat inflammatory, fibrotic, and metabolic conditions. With a commitment to advancing first- and only-in-class drugs, Skye aims to provide new therapeutic outcomes for diseases with significant prevalence and unmet needs.
Driven by science and results, Skye Bioscience's team shares a wealth of experience, expertise, and passion for advancing their unique and proprietary molecules from discovery through commercialization, unlocking the pharmaceutical potential of the endocannabinoid system.
Generated from the website